ArticleBiomedicines2022
Serum CCL2 Is a Prognostic Biomarker for Non-Metastatic Castration-Sensitive Prostate Cancer.
Hiroaki Iwamoto et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
10 papers cite it
this papercites it
ArticleBiomedicines2022
Hiroaki Iwamoto et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.